ILMN Stock Analysis: Illumina Inc
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for geneti
- Latest close
- $273.68
- 20-day change
- +32.13%
- Trend state
- BULLISH
- Classification
- Healthcare · Medical - Diagnostics & Research
Market context
Illumina Inc moved +32.13% over the latest 20-session window. BullRecon currently classifies the broader setup as BULLISH.
Latest report
The latest cached company filing period (FY2025 · $4.3B revenue · $850M net income) is used alongside annual and quarterly history. Values remain tied to their reported period.
Six-dimension read
Health is currently the strongest dimension at 5.5/6, while Value is the lowest at 3.0/6. Scores are comparative research signals, not forecasts.